To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
innovation for industry
Article | Articles ＆ files | Health ＆ life sciences
Research Platform
Clinatec develops new treatments, diagnostics and research methods for applications in oncology, neurodegenerative disease and spinal-cord injury.
Clinatec* brings together multi-disciplinary experts specializing in micro &nanosystems, from clinicians and biologists to technologists. Clinatec fast tracks the development and validation of new therapeutic and palliative solutions.
A unique biomedical research center in the world, Clinatec features an operating room and rooms for welcoming patients participating in clinical trials. Adjoining CEA-Leti's white rooms, the platform relies on experts in micro and nanotechnologies to design innovative miniaturized communicating devices. They meet statutory health requirements from their inception, including active implantable devices (class 3).
Collaboration with partners includes all or part of the development process, such as co-designing, developing, tests, preclinical assessments, and clinical trials.
MAIN ACTIVITIES
Algorithms for closed-circuit biosignal processing
Clinical assessments
KEY FIGURES
6,000 m2 of laboratories and hospital setting
70 doctors and research engineers
10 Theses&Post-docs/year
65 patents
28 M€ of cumulated investments
WITH SUPPORT FROM...
Fondation Edmond J. Safra, Fonds de Dotation Clinatec, Fonds européens, Institut Carnot-Leti, ANR, Fondation Leenaards
IMPLANTATION :
CEA Grenoble, Leti Institute
Top page
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.